The US Food and Drug Administration (FDA) recently announced the approval of the first menthol flavored e-cigarette for sale, which is seen as a key turning point in the development of the e-cigarette industry and has also sparked intense discussions in the public health field. This certification marks a complex balance between FDA's harm reduction potential and youth protection, and may reshape the global regulatory landscape for electronic cigarettes.
During the months long review, the FDA requires applicants to submit dozens of data, including toxicology analysis, preventive measures for adolescent use, and long-term impact studies. The approved product has been confirmed to have harmful substances such as formaldehyde and acetaldehyde in its atomized liquid below the international standard of 97%, and age verification technology and taste lock mechanism are used to reduce the risk of exposure to teenagers. This is not a comprehensive recognition of the menthol flavor, but rather a case approval of the harm reducing effects of specific products, "emphasized Michelle Michal, Director of the FDA Tobacco Products Center.
According to Euromonitor International data, the menthol flavor accounts for 34% of global e-cigarette sales, after the 2020 taste ban in the United States caused the industry to lose nearly $1.8 billion. After this certification, the stock prices of top companies such as Renault Tobacco and JUUL rose by 12%. Analysts predict that it will stimulate a new round of research and development investment, promoting technological iterations such as ceramic cores and low-temperature atomization. However, the FDA has also made it clear that similar products that have not passed the PMTA review will face mandatory delisting.
The American Lung Association quickly issued a statement stating that the cooling sensation of menthol can mask throat irritation and may lead to deeper lung inhalation. A study by Johns Hopkins University shows that users of menthol smoke 27% more times per day than traditional smokers. Even more concerning is that in the latest CDC survey on adolescent tobacco, 9% of high school students have admitted to obtaining prohibited flavored electronic cigarettes through social channels.
The European Commission announced that it will reassess the 2022 ban on menthol, while the UK Medicines and Healthcare Products Regulatory Agency (MHRA) is considering including it in prescription smoking cessation aids. The head of the tobacco control department of the World Health Organization warns: 'We must be vigilant about the tobacco industry using the name of harm reduction for flavor marketing, and Canadian style plain packaging should be a supporting measure.'. "
This certification storm reveals the paradox of the development of new nicotine delivery systems: how to find a balance between promoting adult smoking cessation and preventing new generation addiction when technology is ahead of legislation will become a persistent issue for regulatory agencies in various countries. The FDA also revealed that it is establishing a real-time nicotine release monitoring system and expects to fully implement a post market tracking mechanism by 2024.